Mikael von Euler, Charlotta Liljebris, Magnus Brisander, Per Andersson, Hans Lennernäs, Börje Darpö, Leif Stenke. "XS003, an amorphous re-formulation of nilotinib, demonstrates improved dose linearity and minimal food effect, reducing the risk of QT-prolongation at fed conditions." Blood (2025). https://doi.org/10.1182/blood-2025-5547